Latest News & Features
Big Pharma
Safe harbour provisions can be relied on but their boundaries are still being defined, explain Jeanna Wacker and Tasha Francis Gerasimow of Kirkland & Ellis. 25 August 2022
Americas
Illinois court rules company’s syringe to drug vial system doesn’t infringe | System’s components can be used for other purposes. 25 August 2022
article
Firm appoints new partner with ‘extensive’ in-house and experience | Move follows key office move to Colorado where life sciences sector ‘flourishing’. 23 August 2022
Biotechnology
Protecting new and inventive innovations in this increasingly crowded area is essential, explains Ine Vanderleyden of Mewburn Ellis. 23 August 2022
Americas
Class-action alleges pharma company blocked rival HIV drug | Health insurance trust convinces judge a reverse payment may have been made. 23 August 2022
article
Jones Day has announced that Yi Han Dulkeith has joined the firm’s IP practice in New York. 18 August 2022
Americas
Partnership with San Francisco-based software biotech initially focuses on compounds for five targets | Company uses machine learning to enable structure-based drug design. 18 August 2022
Americas
New Jersey court dismissed a suit regarding an oral antibiotic | Prior art invalidated plaintiff’s four patents. 18 August 2022
Big Pharma
Two decisions from the European Patent Office offer important guidance for healthcare inventions that use computers, says Rosie McDowell of EIP. 16 August 2022
Americas
Dispute over the Enhertu began in 2019 | Antibody drug conjugate tech at issue | American Arbitration Association issued final decision. 16 August 2022